Trending

Karuna

Steve Paul reignites xanomeline research as Karuna CEO

Steve Paul reignites xanomeline research as Karuna CEO

Karuna aims to overcome safety concerns with combination therapy

X

Steve Paul reignites xanomeline research as Karuna CEO

https://pharmaphorum.com/news/steve-paul-reignites-xanomeline-research/

Wellcome Trust awards $8m cash injection to trial schizophrenia drug

Wellcome Trust awards $8m cash injection to trial schizophrenia drug

The Wellcome Trust has awarded $8 million to PureTech’s Karuna to take its schizophrenia drug into mid-stage trials.

X

Wellcome Trust awards $8m cash injection to trial schizophrenia drug

https://pharmaphorum.com/news/wellcome-trust-awards-trial-schizophrenia-drug/

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com